Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Antipsychotic monotherapy (APM) is considered best-acceptable treatment option regardless of antipsychotic class and formulation types for treating schizophrenia. However, antipsychotic polypharmacy (APP) has been also widely utilized in routine clinical practice. Despite APP has some clinical benef...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Psychopharmacol Neurosci
Autori principali: Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean College of Neuropsychopharmacology 2021
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8316655/
https://ncbi.nlm.nih.gov/pubmed/34294613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2021.19.3.434
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi